North Little Rock, Arkansas Clinical Trials

A listing of North Little Rock, Arkansas clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 130 clinical trials
featured
The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension

The objective of the RADIANCE II Pivotal study is to demonstrate the effectiveness and safety of the Paradise System in subjects with Stage 2 hypertension on 0-2 medications at the time of consent. Prior to randomization, subjects will be hypertensive in the absence of hypertension medication.

hypertensive medication
renal angiogram
angiography
antihypertensive drugs
antihypertensive therapy
Central Arkansas Veterans Healthcare System
 (4.6 away) Contact site
  • 877 views
  • 23 Jun, 2021
  • +82 other locations
featured
[Remote] Beyond Listening: A music-based intervention

1.This study is for people with dementia and their family caregiver. 2. The intervention is a 6-week psychoeducational, music-based workshop designed for caregivers of PWD. The caregiver will attend a one-hour, online session for 6 consecutive weeks. Caregivers will implement a daily caregiving routine that incorporates singing, music with movement and …

[Remote] Beyond Listening: A music-based intervention
 (2.9 away) Contact site
  • 0 views
  • 16 Jun, 2021
  • +241 other locations
featured
[Remote] Qualitative Study of Caregiver Use of Assistive Technology

We are seeking caregivers to persons with dementia to participate in interview research. The purpose of the study is to learn more about how caregivers to persons with dementia use technology. Participants will complete a brief online survey and participate in a 50-minute interview. Individuals who complete the study will …

[Remote] Qualitative Study of Caregiver Use of Assistive Technology
 (2.9 away) Contact site
  • 0 views
  • 16 Jun, 2021
  • +240 other locations
featured
Intranasal Migraine Treatment Trial

Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3500 (zavegepant) Intranasal (IN) for the Acute Treatment of Migraine

Baptist Health Center for Clinical Research
 (6.7 away) Contact site
  • 0 views
  • 10 Jun, 2021
  • +81 other locations
A Study of the Safety and Efficacy of Risankizumab in Adult Participants With Plaque Psoriasis Who Have Had a Suboptimal Response to Secukinumab or Ixekizumab

This study will evaluate whether adult participants with moderate to severe plaque psoriasis who have been treated with secukinumab or ixekizumab for at least 6 months and are experiencing a suboptimal response may benefit from switching to risankizumab with regard to skin symptoms, quality of life symptoms and psoriasis symptoms. …

ixekizumab
secukinumab
Arkansas Research Trials /ID# 225497
 (8.0 away) Contact site
  • 49 views
  • 21 Jun, 2021
  • +75 other locations
Efficacy and Safety APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)

This is a 2-part randomized, double-blind, placebo-controlled study of APT-1011 in adults and adolescents (12 years) with EoE. Part A will evaluate the efficacy and safety of APT-1011 3 mg administered HS for the induction of response to treatment (histologic and symptomatic) over 12 weeks. Part B will evaluate histological …

dysphagia
esophagogastroduodenoscopy
Adare Pharmaceuticals
 (1.7 away) Contact site
  • 93 views
  • 14 Jun, 2021
  • +141 other locations
Establishing the Safety and Efficacy of Reloxaliase in Patients With Enteric Hyperoxaluria

The purpose of this study is to determine the efficacy, durability and long-term safety of reloxaliase in patients with enteric hyperoxaluria.

Applied Research Center of Arkansas
 (8.8 away) Contact site
  • 7 views
  • 11 Jun, 2021
  • +73 other locations
A Study to Evaluate the Efficacy and Safety of PF-06480605 in Adult Participants With Moderate to Severe Ulcerative Colitis

This phase 2b study is designed to have all subjects go into a 12 week induction period to compare different doses of study drug against placebo. After induction is complete all subjects will receive active therapy for 40 weeks, followed by a 12 week follow up period.

Lynn Institute of the Ozarks
 (6.9 away) Contact site
  • 32 views
  • 23 Jun, 2021
  • +246 other locations
Immune Modulators for Treating COVID-19

ACTIV-1 IM is a master protocol designed to evaluate multiple investigational agents for the treatment of moderately or severely ill patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The research objectives are to evaluate each agent with respect to speed of recovery, mortality, illness severity, and hospital resource …

University of Arkansas Medical Sciences
 (2.9 away) Contact site
  • 0 views
  • 23 Jun, 2021
  • +83 other locations
RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA)

To evaluate the treatment effect of seladelpar on composite biochemical improvement in cholestasis markers based on ALP and total bilirubin and to evaluate the safety of seladelpar over 12 months of treatment compared to placebo

Arkansas Diagnostic Center
 (4.6 away) Contact site
  • 0 views
  • 23 Jun, 2021
  • +22 other locations